Can Covishield Cause Blood Clots and Brain Stroke?

By iastoppers.com

AstraZeneca confirms very rare cases of blood clots linked to its Covid-19 vaccine, Covishield, raising critical safety questions

The Rare Concern

Thrombosis with Thrombocytopenia Syndrome (TTS) involves low platelet counts and clot formation, linked to Covishield in rare instances

What is TTS?

With over 175 crore doses administered in India, Covishield’s safety profile is under scrutiny amid rare but severe complications

Global Usage Impact

Facing lawsuits in the UK, AstraZeneca confronts claims of permanent injuries caused by vaccine-induced blood clots

Legal Challenges

Recognise TTS symptoms include breathlessness, chest pain, severe headaches, and unusual skin bruising beyond the injection site

Symptoms

Data reveals a very low incidence of TTS, with about four cases per million doses, highlighting its rarity

Statistical

Contrasting Covishield, Covaxin shows no reported thromboembolic events, underlining differences in vaccine formulations

Vaccine Comparison

Despite the risks, the benefits of Covishield in preventing Covid-19 infections and reducing mortality are emphasised

Continued Vigilance